Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Ahmet Kürşat Azkur, Mübeccel Akdiş, Dilek Azkur, et al.
Allergy (2020) Vol. 75, Iss. 7, pp. 1564-1581
Open Access | Times Cited: 1105

Showing 1-25 of 1105 citing articles:

Features, Evaluation and Treatment Coronavirus (COVID-19)
Marco Cascella, Michael Rajnik, Arturo Cuomo, et al.
StatPearls (2020)
Closed Access | Times Cited: 2796
The cytokine storm and COVID‐19
Biying Hu, Shaoying Huang, Lianghong Yin
Journal of Medical Virology (2020) Vol. 93, Iss. 1, pp. 250-256
Open Access | Times Cited: 1450
Risk factors for severe and critically ill COVID‐19 patients: A review
Yadong Gao, Mei Ding, Xiang Dong, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 428-455
Open Access | Times Cited: 1282
Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors
Urszula Radzikowska, Mei Ding, Ge Tan, et al.
Allergy (2020) Vol. 75, Iss. 11, pp. 2829-2845
Open Access | Times Cited: 521
The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 496
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Carlo Cervia, Jakob Nilsson, Yves Zurbuchen, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 2, pp. 545-557.e9
Open Access | Times Cited: 386
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Carl A. Pierce, Paula Preston‐Hurlburt, Yile Dai, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 564
Open Access | Times Cited: 357
COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung, Melissa N. Thone, Young Jik Kwon
Advanced Drug Delivery Reviews (2020) Vol. 170, pp. 1-25
Open Access | Times Cited: 347
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
Sonia Villapol
Translational research (2020) Vol. 226, pp. 57-69
Open Access | Times Cited: 335
Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis
Xiaoming Li, Chao Liu, Zhi Mao, et al.
Critical Care (2020) Vol. 24, Iss. 1
Open Access | Times Cited: 305
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Duraisamy Kempuraj, Govindhasamy Pushpavathi Selvakumar, Mohammad Ejaz Ahmed, et al.
The Neuroscientist (2020) Vol. 26, Iss. 5-6, pp. 402-414
Open Access | Times Cited: 266
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Yannick Galipeau, Matthew Greig, George Liu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 242
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Abdul Aleem, Abdul Samad, Amy Slenker
(2021) Vol. 01, pp. 01-01
Closed Access | Times Cited: 242
Lymphocyte Subset Counts in COVID‐19 Patients: A Meta‐Analysis
Wei Huang, Julie Bérubé, Michelle McNamara, et al.
Cytometry Part A (2020) Vol. 97, Iss. 8, pp. 772-776
Open Access | Times Cited: 219
Post-COVID-19 acute sarcopenia: physiopathology and management
Karolina Piotrowicz, Jerzy Gąsowski, Jean‐Pierre Michel, et al.
Aging Clinical and Experimental Research (2021) Vol. 33, Iss. 10, pp. 2887-2898
Open Access | Times Cited: 217
ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response
Cheng Wang, Mingzi Zhang, Gustavo Garcia, et al.
Cell stem cell (2021) Vol. 28, Iss. 2, pp. 331-342.e5
Open Access | Times Cited: 194
COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis
Kyung Mok Sohn, Sung‐Gwon Lee, Hyeon Ji Kim, et al.
Journal of Korean Medical Science (2020) Vol. 35, Iss. 38
Open Access | Times Cited: 185
Persistent complement dysregulation with signs of thromboinflammation in active Long Covid
Carlo Cervia, Sarah C. Brüningk, Tobias Hoch, et al.
Science (2024) Vol. 383, Iss. 6680
Open Access | Times Cited: 182
Genetics Insight for COVID-19 Susceptibility and Severity: A Review
Ingrid Fricke-Galindo, Ramcés Falfán‐Valencia
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 180
Controlling Cytokine Storm Is Vital in COVID-19
Lu Tang, Zhinan Yin, Yu Hu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 170
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes
Edison Cano Cevallos, Xavier Fonseca Fuentes, Cristina Corsini Campioli, et al.
CHEST Journal (2020) Vol. 159, Iss. 3, pp. 1019-1040
Open Access | Times Cited: 163
Factors related to mental health of inpatients with COVID-19 in Wuhan, China
Yanyu Hu, Yingying Chen, Yixiong Zheng, et al.
Brain Behavior and Immunity (2020) Vol. 89, pp. 587-593
Open Access | Times Cited: 160
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
Bingqing Xia, Xu-Rui Shen, Yang He, et al.
Cell Research (2021) Vol. 31, Iss. 8, pp. 847-860
Open Access | Times Cited: 152
Page 1 - Next Page

Scroll to top